Structure-signal relationships of the δ-opioid-receptor (DOR)-selective agonist KNT-127 - Part I: Impact of the morphinan skeleton on the G-protein-biased DOR agonism

Tsuyoshi Saitoh,Keita Kajino,Tomoya Sugai,Ryoji Kise,Riko Suzuki,Akihisa Tokuda,Yuki Sekiya,Tomoya Kakumoto,Risako Katamoto,Noriki Kutsumura,Yasuyuki Nagumo,Asuka Inoue

DOI: https://doi.org/10.26434/chemrxiv-2024-st481

2024-10-17

Abstract:The δ-opioid receptor (DOR) is a promising target for developing novel analgesics due to its lower risk of causing side effects compared to the μ-opioid receptor (MOR), which is commonly associated with dependence, respiratory depression, and other adverse effects. KNT-127, a DOR-selective agonist with a morphinan skeleton, offers analgesic and antidepressant benefits without inducing convulsions at therapeutic doses, unlike the conventional DOR agonist SNC80. While previous studies have suggested that KNT-127 exhibits reduced β-arrestin recruitment, a signaling pathway implicated in adverse opioid effects, the ligand structural basis for this biased signaling remains unclear. In this study, we explored the structure–signal relationships of KNT-127, focusing on its quinoline moiety. Modifying the quinoline moiety by removing the aromatic rings reduced DOR selectivity and potency in relation to G-protein activation while diminishing both the potency and efficacy of β-arrestin recruitment. These results suggest that the morphinan skeleton is critical for reduced β-arrestin recruitment, while the quinoline moiety differentially modulates G-protein activation and β-arrestin recruitment. Together, our study thus provides structural insights into the G-protein-biased agonism of DOR agonists, guiding the design of safer DOR-targeting therapeutics.

Chemistry